Your browser doesn't support javascript.
loading
Prediction of carotid intima-media thickness and its relation to cardiovascular events in persons with type 2 diabetes.
Winckler, Karoline; Thorsteinsson, Birger; Wiinberg, Niels; Jensen, Andreas Kryger; Lundby-Christensen, Louise; Heitmann, Berit Lilienthal; Lund, Søren S; Krarup, Thure; Jensen, Tonny; Vestergaard, Henrik; Breum, Leif; Sneppen, Simone; Boesgaard, Trine; Madsbad, Sten; Gluud, Christian; Vaag, Allan; Almdal, Thomas P; Tarnow, Lise.
Afiliação
  • Winckler K; Department of Endocrinology and Nephrology, Nordsjaellands Hospital, Hilleroed, Denmark. Electronic address: Karoline.winckler@regionh.dk.
  • Thorsteinsson B; Department of Endocrinology and Nephrology, Nordsjaellands Hospital, Hilleroed, Denmark; University of Copenhagen, Denmark.
  • Wiinberg N; Department of Physiology and Nuclear Medicine, Bispebjerg and Frederiksberg Hospital, Denmark. Electronic address: Niels.Wiinberg@regionh.dk.
  • Jensen AK; Section of Biostatistics, Institute of Public Health, University of Copenhagen, Denmark; Department of Research, Nordsjaellands Hospital, Hilleroed, Denmark. Electronic address: Andreas.emil.kryger.jensen@regionh.dk.
  • Lundby-Christensen L; Steno Diabetes Center Sjaelland, Holbaek, Denmark. Electronic address: lochris@regionsjaelland.dk.
  • Heitmann BL; Research Unit for Dietary Studies, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Denmark; Department of Public Health, Section for General Practice, University of Copenhagen, Copenhagen, Denmark. Electronic address: Berit.Lilienthal.Heitmann@regionh.dk.
  • Lund SS; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Ingelheim, Germany.
  • Krarup T; Department of Endocrinology, Copenhagen University Hospital, Bispebjerg, Denmark.
  • Jensen T; Department of Endocrinology, Rigshospitalet, University of Copenhagen, Denmark.
  • Vestergaard H; University of Copenhagen, Denmark; Department of Endocrinology, Copenhagen University Hospital, Herlev, Denmark,; The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Denmark.
  • Breum L; Department of Medicine, University Hospital Koege, Denmark.
  • Sneppen S; Department of Medicine, Copenhagen University Hospital, Gentofte, Denmark.
  • Boesgaard T; Novo Nordisk, Soeborg, Denmark.
  • Madsbad S; University of Copenhagen, Denmark; Department of Endocrinology, Copenhagen University Hospital, Hvidovre, Denmark.
  • Gluud C; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Vaag A; AstraZeneca, Göteborg, Sweden.
  • Almdal TP; Department of Endocrinology, Rigshospitalet, University of Copenhagen, Denmark.
  • Tarnow L; Department of Research, Nordsjaellands Hospital, Hilleroed, Denmark; Steno Diabetes Center Sjaelland, Holbaek, Denmark. Electronic address: litar@regionsjaelland.dk.
J Diabetes Complications ; 34(10): 107681, 2020 10.
Article em En | MEDLINE | ID: mdl-32741659
ABSTRACT

AIMS:

To investigate measures of carotid intima-media thickness (IMT) and conventional cardiovascular (CV) risk factors as predictors of future carotid IMT, and the prediction of CV events during follow-up based on measures of carotid IMT.

METHODS:

Observational longitudinal study including 230 persons with type 2 diabetes (T2D).

RESULTS:

Mean age at follow-up was 66.7 (SD 8.5) years, 30.5% were women and mean body mass index (BMI) was 31.8 (4.4) kg/m2. Carotid IMT was measured at baseline, after 18 months of intervention in the Copenhagen Insulin and Metformin Therapy (CIMT) trial and after a mean follow-up of 6.4 (1.0) years. Baseline carotid IMT, carotid IMT after 18 months' intervention, and CV risk factors (age, sex and baseline systolic blood pressure) gave the best prediction of carotid IMT (root mean-squared error of prediction of 0.106 and 95% prediction error probability interval of -0.160, 0.204).

CONCLUSIONS:

Measures of carotid IMT combined with CV risk factors at baseline predicts attained carotid IMT better than measures of carotid IMT or CV risk factors alone. Carotid IMT did not predict CV events, and the present results do not support the use of carotid IMT as a predictor of CV events in persons with T2D.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Espessura Intima-Media Carotídea Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Espessura Intima-Media Carotídea Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article